Thyro-Tablets

Thyro-Tablets are used for thyroid replacement therapy in all conditions of inadequate natural production of thyroid hormones in dogs. Hypothyroidism is the generalized metabolic disease resulting from the deficiency of the thyroid hormones levothyroxine (T4) and liothyronine (T3). Thyro-Tablets supplies levothyroxine sodium (L-thyroxine), which not only replaces depleted T4 but also acts as a substrate for the physiologic deiodination to liothyronine (T3). Thyro-Tablets administered alone will result in complete physiologic thyroid replacement in dogs.

Thyro-Tablets are formulated to minimize product degradation for maximum potency throughout their stated shelf life. Other formula factors contributing to optimum stability and product reliability are: particle size, granulation process, disintegrate selection, active ingredient source and synthesis and excipients. It is available in nine dosage strengths which are color coded for easy identification.

Canine hypothyroidism is usually primarily due to atrophy of the thyroid gland. It usually occurs in intact, middle-aged, and older dogs although the condition will sometimes be seen in younger dogs of the larger breeds. Neutered animals of either sex are also frequently affected, regardless of age. Clinical signs of hypothyroidism in dogs include, but not limited to, lethargy, preference for warmth, increases body weight, stiff and slow movements, atrophying of epidermis and thickening of dermis, shortening or absence of estrus or lack of libido.

Contraindications:
Levothyroxine sodium therapy is contraindicated in thyrotoxicosis, acute myocardial infarction and uncorrected adrenal insufficiency. Use in pregnant bitches has not been evaluated.

Storage:
Store at 20°-25°C (68°-77°F) with excursions between 15°-30°C (59°-86°F) and protect from light.